Stock Financial Ratios

MRTX / Mirati Therapeutics, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price28.70
Volume320,800.00
Market Cap ($M)291.92
Enterprise Value ($M)211.56
Book Value ($M)48.31
Book Value / Share1.94
Price / Book10.52
NCAV ($M)44.42
NCAV / Share2.45
Price / NCAV11.03
Income Statement (mra) ($M)
Revenue0.00
EBITDA-83.78
Net Income-83.12
Balance Sheet (mrq) ($M)
Cash & Equivalents20.78
Cash / Share1.05
Assets82.06
Liabilities13.91
Quick Ratio3.97
Current Ratio3.97
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-1.72
Return on Assets (ROA)-1.31
Return on Equity (ROE)-1.72
Identifiers and Descriptors
CUSIP60468T105
Central Index Key (CIK)1576263
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
60468T955
60468T905
Share Statistics
Common Stock Shares Outstanding19,937,095
Common Shares Outstanding24,939,797
Preferred Stock Shares Outstanding0
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Equity Per Share0.00
Liabilities Per Share0.70
Minority Interest Per Share0.00
Assets Per Share3.29
Inventory Work In Progress Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Cash And Equivalents Per Share0.83
Accounts Payable Per Share0.00
Debt Per Share0.00
Inventory Per Share0.00
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Property Plant And Equipment Net Per Share0.00
Liabilities Current Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Assets Current Per Share3.18
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Cash Per Share1.05
Inventory Raw Materials Per Share0.00
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00

Peers - Pharmaceutical Preparations (2834)

Related News Stories

Spectrum Pharmaceuticals: Continued Upside In 2018

1h seekingalpha
While safety and tolerability concerns remain for poziotinib, updated results from ongoing studies will likely spur upside this year. (78-1)

ROTY Edition 1 Volume 82: Launch Preview And Adding To A Position

2018-02-23 seekingalpha
I remind readers of my recent blog post which gives a preview of the ROTY MarketPlace launch to help them decide if the service is appropriate for their needs. (225-3)

ROTY Edition 1 Volume 81: We Have A Launch Date!

2018-02-21 seekingalpha
February continues to be our worst month yet, but I focus on positioning the model account for success based on our current plan. (197-0)

Biotechs: Still Well Placed For More Gains

2018-02-20 seekingalpha
Big Pharma has to build out pipelines in new areas, and M&A is a compelling alternative. (719-3)

CUSIP: 60468T105